SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Wadenvik Hans 1955)
 

Search: WFRF:(Wadenvik Hans 1955) > (2000-2004) > Characterization of...

Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A.

Lindgren, A (author)
Wadenvik, Hans, 1955 (author)
Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin, Avdelningen för internmedicin,Institute of Internal Medicine, Dept of Medicine
Tengborn, L (author)
 (creator_code:org_t)
2002
2002
English.
In: Haemophilia : the official journal of the World Federation of Hemophilia. - 1351-8216. ; 8:5, s. 644-8
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Different methods can be used for the detection and quantification of inhibitors or antibodies to coagulation factor VIII (FVIII). Traditionally, clotting assays have been used, in particular the Bethesda assay. These assays have, however, several shortcomings, due to the complex reaction kinetics of some inhibitors and a low sensitivity to low-titre antibodies. In addition, a universal FVIII inhibitor standard is lacking. Furthermore, clotting assays do not detect noninhibitory antibodies. Use of ELISAs has been described and FVIII from various commercially available FVIII concentrates has been used as target antigen in the assays. In the present study, we systematically explored the influence of different FVIII concentrates on the performance of an ELISA for detection of FVIII antibodies. The described ELISA was also used for further characterization of FVIII inhibitors in patients with acquired and congenital haemophilia A. We found that the source of FVIII had a substantial impact on the frequency of antibody detection. Albumin-free recombinant FVIII as target antigen gave the highest sensitivity for the assay, whereas plasma-derived concentrates containing a high level of von Willebrand factor (vWF) gave the lowest sensitivity. Presumably vWF interferes with the binding of antibodies to FVIII. We suggest that albumin-free recombinant FVIII should be used as target antigen when ELISAs are used for detection of FVIII antibodies.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)

Keyword

Antibodies
blood
Autoantibodies
blood
Blood Coagulation Factor Inhibitors
immunology
Enzyme-Linked Immunosorbent Assay
methods
Factor VIII
immunology
Hemophilia A
blood
Humans
Immunoglobulin A
analysis
Immunoglobulin G
analysis
Immunoglobulin M
analysis
Recombinant Proteins
immunology
Sensitivity and Specificity

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Lindgren, A
Wadenvik, Hans, ...
Tengborn, L
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Hematology
Articles in the publication
Haemophilia : th ...
By the university
University of Gothenburg

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view